Rosuvastatin counteracts vessel arterialisation and sinusoid capillarisation, reduces tumour growth, and prolongs survival in murine hepatocellular carcinoma.

MLA

Tijeras-Raballand, Annemilaï, et al. “Rosuvastatin Counteracts Vessel Arterialisation and Sinusoid Capillarisation, Reduces Tumour Growth, and Prolongs Survival in Murine Hepatocellular Carcinoma.” Gastroenterology Research and Practice, vol. 2010, 2010, p. 640797. EBSCOhost, https://doi.org/10.1155/2010/640797.

APA

Tijeras-Raballand, A., Hainaud-Hakim, P., Contreres, J.-O., Gest, C., Le Henaff, C., Levy, B. I., Pocard, M., Soria, C., & Dupuy, E. (2010). Rosuvastatin counteracts vessel arterialisation and sinusoid capillarisation, reduces tumour growth, and prolongs survival in murine hepatocellular carcinoma. Gastroenterology Research and Practice, 2010, 640797. https://doi.org/10.1155/2010/640797

Chicago

Tijeras-Raballand, Annemilaï, Patricia Hainaud-Hakim, Jean-Olivier Contreres, Caroline Gest, Carole Le Henaff, Bernard I Levy, Marc Pocard, Claudine Soria, and Evelyne Dupuy. 2010. “Rosuvastatin Counteracts Vessel Arterialisation and Sinusoid Capillarisation, Reduces Tumour Growth, and Prolongs Survival in Murine Hepatocellular Carcinoma.” Gastroenterology Research and Practice 2010: 640797. doi:10.1155/2010/640797.